Every rule your marketing answers to.

Warrant reviews your marketing against 3,388 rules from 1,267 regulators across 11 countries. Every flag is cited to its source. Search the full library below.

Coverage includes the FTC, FDA, CFPB, SEC, FINRA, NCUA, FDIC, OCC, NAIC, and regulators from all 50 U.S. states, the European Union, Canada, and more.

Get a free homepage compliance scan

Regulation guides

CMS Licensing of Marketing Reps

Medicare Advantage and Part D lead forms and event materials must tell beneficiaries a licensed agent may contact them, may not share their data with other TPMOs without prior express written consent, and must announce any switch from education to marketing at events.

42 CFR 422.2264(c), 422.2274(g)(3)-(4); 42 CFR 423.2264(c), 423.2274(g)(3)-(4)

CMS Medicare Advantage and Prescription Drug Plans

Medicare Advantage and Part D marketing must describe benefits and costs accurately, must not imply government endorsement, must cite current star ratings, and must carry a Material ID and TTY number where required.

42 CFR 422.2262(a), (c)-(d), 422.2263(b)-(c), 422.2265(b); 42 CFR 423.2262(a), (c)-(d), 423.2263(b)-(c), 423.2265

CMS Medicare Marketing

Medicare Advantage and Part D marketing may offer only nominal-value gifts available to everyone regardless of enrollment, no cash or cash equivalents, and must make only accurate, supported comparisons with Original Medicare or other plans.

42 CFR 422.2262 (introductory text); 42 CFR 422.2263(b)(1), (b)(2), (b)(5); 42 CFR 423.2262; 42 CFR 423.2263(b)(1), (b)(2), (b)(5)

CMS Medicare Marketing Guidelines

Third-party Medicare marketers (agents, brokers, call centers, lead generators) must include the CMS TPMO disclaimer stating how many organizations and plans they represent and referring people to Medicare.gov and 1-800-MEDICARE; from CY2027 the SHIP reference is dropped and on calls it must come before plan benefits are discussed.

42 CFR 422.2267(e)(41); 42 CFR 423.2267(e)(41); 42 CFR 422.2262(a)(1)(ix), (xvii); CY2027 MA/Part D final rule (FR Doc. 2026-06600)

CMS Physician Payment Marketing Transparency

When a physician or other health professional endorses a drug, device or health service, any payment or other material connection to the advertiser must be clearly disclosed with the endorsement; the Sunshine Act's Open Payments reporting does not itself require ad disclosures.

15 U.S.C. 45(a)(1); 16 CFR 255.0(f), 255.1(a), 255.3, 255.5(a)

CMS Skilled Nursing Facility Marketing

Nursing home and skilled nursing facility marketing must not state admission conditions federal law bans (waiving Medicare or Medicaid rights, private-pay promises, third-party guarantees) and must describe Medicare coverage and CMS star ratings accurately.

42 CFR 483.15(a)(2)-(3); 42 U.S.C. 1395i-3(c)(5)(A); 42 U.S.C. 1396r(c)(5)(A); 15 U.S.C. 45(a)(1)

CMS Stark Law Marketing Relationship Violations

Physician-owned hospitals must disclose physician ownership on their public websites and in public advertising, and marketing to physicians must not offer benefits tied to referrals for designated health services.

42 CFR 411.362(b)(3)(ii)(C); 42 U.S.C. 1395nn(a)(1); 42 U.S.C. 1320a-7b(b)(2)

CMS Telehealth Service Marketing

Telehealth marketing that mentions Medicare must state coverage accurately with eligibility and cost-sharing qualifications and must not use Medicare or HHS names in a way that implies government approval or affiliation.

42 U.S.C. 1320b-10(a)(1); 15 U.S.C. 45(a)(1); 42 CFR 410.78

Telehealth Marketing

Telehealth ads must not overstate what virtual care can do, guarantee prescriptions or outcomes, or imply Medicare or government endorsement.

15 U.S.C. 45(a)(1), 52(a); 42 U.S.C. 1320b-10(a)(1)

Browse by category

Browse by jurisdiction

Browse by regulator